- Home
- NVCT vs GHI Comparison
NVCT vs GHI Comparison
Compare NVCT & GHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NVCT | GHI |
|---|---|---|
| Founded | 2020 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 197.0M | 161.5M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | NVCT | GHI |
|---|---|---|
| Price | $7.64 | $6.84 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $15.33 | $13.00 |
| AVG Volume (30 Days) | 87.9K | ★ 188.2K |
| Earning Date | 11-04-2025 | 02-19-2026 |
| Dividend Yield | N/A | ★ 21.86% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.17 |
| Revenue | N/A | ★ $26,247,399.00 |
| Revenue This Year | N/A | $201.02 |
| Revenue Next Year | N/A | $2.87 |
| P/E Ratio | ★ N/A | $40.13 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.03 | $6.01 |
| 52 Week High | $11.52 | $13.29 |
Technical Indicators
Market Signals| Indicator | NVCT | GHI |
|---|---|---|
| Relative Strength Index (RSI) | 57.08 | 46.32 |
| Support Level | $7.57 | $6.99 |
| Resistance Level | $7.91 | $7.35 |
| Average True Range (ATR) | 0.38 | 0.36 |
| MACD | -0.05 | 0.05 |
| Stochastic Oscillator | 33.76 | 42.62 |
Price Performance
Historical ComparisonAbout NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
About GHI Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests
Greystone Housing Impact Investors LP engaged in acquiring a portfolio of mortgage revenue bonds (MRBs) that are issued by state and local housing authorities to provide construction and/or permanent financing for affordable multifamily housing, seniors housing, and commercial properties. It has four reportable segments, namely Affordable Multifamily MRB Investments, Seniors and Skilled Nursing MRB Investments, MF Properties, and Market-Rate Joint Venture Investments. It generates the majority of its revenue from the Affordable Multifamily MRB Investments segment.